US FDA accepts IND for TxCell's Crohn's cell therapy; Firm eyes European CRO for US trial
TxCell is set to expand a trial of its candidate Crohn’s disease cell therapy to the US after the FDA accepted its IND application.
Archives for June 29, 2015
Sequenom case leaves pharma confused over patent law
US intellectual property (IP) rules and a string of recent court cases are reducing the types of inventions pharma companies can patent, and “calling into question entire portfolios,” says a specialist lawyer.
Pfizer snaps up GSK's legacy meningitis vaccines for $130m
GSK has divested two meningitis vaccines to Pfizer to appease regulators following its three-part asset exchange with Novartis.
Novasep expanding conjugation capability to help simplify ADC supply chain
Novasep is investing €10m ($11m) in a bio-conjugation plant it says will offer drugmakers a more complete antibody-drug conjugation (ADC) service.